Cafe Au Lait patches

Neurofibromatosis- 1 aka von Recklinghausen's disease

(Chrom 17 - 17 letters in neurofibromatosis; and also in 'von recklinghausens' dz of bone)

  1. Most common of the neurocutaneous syndromes (1/3000)
  2. AD inheritance (50%) with full penetrance
  3. Sporadic occurrence (50%)
  4. Males = females
  5. Gene localized to chromosome 17
  6. Diagnosis made if meets 2 of the 7 criteria

NF COLOR

Dx= 2 criteria met
Associated concerns to consider:

Tuberous Sclerosis (Autosomal dominant, chrom 9)

DIAGNOSIS:

Major:

Face and skin (4)
  1. Facial angiofibromas (adeoma sebaceum) appear in childhood.
  2. Nail: Nontraumatic ungual or periungual fibroma
  3. Ash leaf spots (>3): white, hypopigmented macules (thumb or leaf shaped), may be >100, anywhere, often on trunk/buttocks. Hard to see in light skinned infants. Look closely. Can use a woods/UV lamp. These are usually the first lesions to appear.
  4. Shagreen patch (connective tissue nevus), especially in lumbosacral region

'Masses: nodules and -oma's' (7)

Minor:

There are great pictures in Zitelli of each of these diagnostic characteristics (too big a file to add to the e-mail).  There are other neurocutaneous syndromes that you need to consider  when presented with a patient with neurologic symptoms, intracranial lesions, cutaneous abnormalities, mental retardation or developmental delay.

CHLA Chief Resident Pearl Jan 2005
CHLA Board Review 2005

Sturge-Weber Syndrome, Port Wine Stain, Kasabach-Merritt, Klippel-Trenaunay-Weber, type-1 (NF-1), tuberous sclerosis)

  1. Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype. Brems H; Chmara M; Sahbatou M; Denayer E; Taniguchi K; Kato R; Somers R; Messiaen L; De Schepper S; Fryns JP; Cools J; Marynen P; Thomas G; Yoshimura A; Legius E.  Nat Genet. 2007 Sep;39(9):1120-6. Epub 2007 Aug 19. Abstract: We report germline loss-of-function mutations in SPRED1 in a newly identified autosomal dominant human disorder. SPRED1 is a member of the SPROUTY/SPRED family of proteins that act as negative regulators of RAS->RAF interaction and mitogen-activated protein kinase (MAPK) signaling. The clinical features of the reported disorder resemble those of neurofibromatosis type 1 and consist of multiple cafe-au-lait spots, axillary freckling and macrocephaly. Melanocytes from a cafe-au-lait spot showed, in addition to the germline SPRED1 mutation, an acquired somatic mutation in the wild-type SPRED1 allele, indicating that complete SPRED1 inactivation is needed to generate a cafe-au-lait spot in this syndrome. This disorder is yet another member of the recently characterized group of phenotypically overlapping syndromes caused by mutations in the genes encoding key components of the RAS-MAPK pathway. To our knowledge, this is the first report of mutations in the SPRY (SPROUTY)/SPRED family of genes in human disease.